Narayana Hrudayalaya Shares Surge 10% on Strong Q2 Results and Expansion Plans

1 min read     Updated on 17 Nov 2025, 10:39 AM
scanx
Reviewed by
Ashish ThakurScanX News Team
Overview

Narayana Hrudayalaya's shares rose 10% following the announcement of robust Q2 FY24 results and ambitious expansion plans. The company reported a 20.30% YoY increase in revenue to 1,643.79 crore and a 29.90% YoY growth in net profit to 258.83 crore. Narayana Hrudayalaya plans to expand its bed capacity from the current 5,750 to over 7,650 beds by FY30, signaling confidence in growing healthcare demand in India.

24901804

*this image is generated using AI for illustrative purposes only.

Shares of Narayana Hrudayalaya , a prominent healthcare operator in India, witnessed a significant uptick of 10% following the announcement of its robust quarterly results and ambitious expansion plans.

Strong Q2 Performance

The company reported impressive financial results for the second quarter:

Metric Q2 FY24 YoY Growth
Revenue 1,643.79 20.30
Net Profit 258.83 29.90

The substantial growth in both revenue and net profit underscores Narayana Hrudayalaya's strong operational performance and increasing market demand for its healthcare services.

Expansion Strategy

Narayana Hrudayalaya has unveiled plans for significant expansion, aiming to increase its bed capacity:

Timeline Current Capacity Targeted Capacity
Current 5,750 beds -
By FY30 - Over 7,650 beds

This expansion strategy signals the company's commitment to aggressive growth and its confidence in the increasing demand for quality healthcare services in India.

Market Response

The market responded positively to Narayana Hrudayalaya's performance and future outlook:

  • Share price surged by 10%
  • Investors showed enthusiasm for the company's growth trajectory
  • The expansion plans were well-received, indicating market confidence in the company's long-term strategy

Narayana Hrudayalaya's strong quarterly performance, coupled with its ambitious expansion plans, has positioned the company favorably in the competitive healthcare sector. The significant increase in share price reflects investor optimism about the company's future prospects and its ability to capitalize on the growing healthcare market in India.

Historical Stock Returns for Narayana Hrudayalaya

1 Day5 Days1 Month6 Months1 Year5 Years
+9.95%+6.38%+9.83%+10.02%+52.88%+429.60%
Narayana Hrudayalaya
View in Depthredirect
like19
dislike

Narayana Hrudayalaya Reports Robust Q2 FY26 Results with 29.6% Jump in Net Profit

1 min read     Updated on 14 Nov 2025, 11:52 PM
scanx
Reviewed by
Riya DeyScanX News Team
Overview

Narayana Hrudayalaya's Q2 FY26 results show significant growth. Revenue increased by 20.3% to ₹16,438.00 million, EBITDA grew 28.3% to ₹4,265.00 million, and net profit rose 29.6% to ₹2,583.00 million. India revenue grew 8.8%, while Cayman revenue surged 78.1%. The company plans to expand bed capacity from 7,600+ to over 7,685 by FY30, with projects in Bangalore, Raipur, and Kolkata. Digital transformation initiatives are underway to enhance patient experience and operational efficiency.

24690174

*this image is generated using AI for illustrative purposes only.

Narayana Hrudayalaya , a leading healthcare provider, has reported strong financial results for the second quarter of fiscal year 2026, demonstrating significant growth across key metrics.

Financial Highlights

The company's consolidated performance for Q2 FY26 showed impressive year-over-year improvements:

Metric Q2 FY26 Q2 FY25 YoY Change
Revenue ₹16,438.00 ₹13,667.00 20.3%
EBITDA ₹4,265.00 ₹3,323.00 28.3%
EBITDA Margin 25.9% 24.3% 160 bps
Net Profit ₹2,583.00 ₹1,993.00 29.6%
Net Profit Margin 15.7% 14.6% 110 bps

Operational Performance

The company's strong financial results were underpinned by robust operational performance:

  • India Revenue grew by 8.8% year-over-year to ₹12,347.00 million
  • Cayman Revenue saw a substantial increase of 78.1% to ₹4,316.00 million

Segment-wise Performance

Narayana Hrudayalaya's business mix for Q2 FY26 in India hospital operations was as follows:

  • Owned Hospitals: 73%
  • Operated Hospitals: 25%
  • Heart Centres: 1%

The company's specialty profile showed a diverse mix, with Cardiac Sciences leading at 33%, followed by Oncology at 15%, and Medicine and GI sciences at 14%.

Key Financial Ratios

As of September 30, 2025, Narayana Hrudayalaya reported strong financial ratios:

  • Debt Equity Ratio: 0.58
  • Interest Service Coverage Ratio: 7.99
  • Current Ratio: 2.20
  • Operating Margin: 24.49%
  • Net Profit Margin: 15.71%

Management Commentary

Dr. Emmanuel Rupert, Managing Director & Group CEO, stated, "Our Q2 FY26 results reflect the continued strength of our healthcare model and the dedication of our team. The significant growth in revenue and profitability demonstrates the resilience of our operations and the increasing demand for quality healthcare services."

Future Outlook

Narayana Hrudayalaya continues to focus on expanding its presence in key regions. The company plans to increase its bed capacity from the current 7,600+ to over 7,685 by FY30, with expansion projects in Bangalore, Raipur, and Kolkata.

The company is also making strides in digital transformation, with initiatives aimed at enhancing patient safety and experience, as well as improving operational efficiencies.

Narayana Hrudayalaya's strong Q2 FY26 performance, coupled with its expansion plans and digital initiatives, positions the company well for continued growth in the healthcare sector.

Note: All financial figures are in Indian Rupees (₹) unless otherwise stated.

Historical Stock Returns for Narayana Hrudayalaya

1 Day5 Days1 Month6 Months1 Year5 Years
+9.95%+6.38%+9.83%+10.02%+52.88%+429.60%
Narayana Hrudayalaya
View in Depthredirect
like19
dislike
More News on Narayana Hrudayalaya
Explore Other Articles
1,928.00
+174.50
(+9.95%)